Fact 9: The Potential Role of Antidiabetic Drugs in Dementia Prevention
Research is currently underway to understand the potential role of antidiabetic drugs in preventing or delaying dementia. Some of these drugs, such as metformin and the class of drugs known as GLP-1 (glucagon-like peptide-1) agonists, have shown promise in preliminary studies.
These drugs work to improve blood sugar control in people with diabetes, but they might also have protective effects on the brain. For example, metformin has been shown to have anti-inflammatory and antioxidant effects, potentially protecting brain cells from damage.
GLP-1 agonists, on the other hand, are thought to reduce inflammation in the brain and have a positive effect on brain function. Some studies have suggested that people with diabetes who take these drugs may have a lower risk of developing dementia.
However, it’s important to note that while these findings are promising, more extensive research is needed to confirm these effects and understand how these drugs might be used in dementia prevention or treatment. As always, any medication use should be under the guidance of a healthcare provider. (9)
